文献速递神经核医学肿瘤 PET/CT

68Ga-PSMA-11 PET/CT检出同期复发前列腺癌患者胶质母细胞瘤术后残留

68Ga-Prostate-Specific Membrane Antigen 11 PET/CT Detects Residual Glioblastoma After Radical Surgery in a Patient With Synchronous Recurrent Prostate Cancer: A Case Report.
PubMed 文献 · Clin Nucl Med · 2020-01-01

本文报道一名67岁有前列腺癌病史的男性,在胶质母细胞瘤根治术后行68Ga-PSMA-11 PET/CT重新分期前列腺癌时,PET显像显示手术区胶质母细胞瘤残留病灶有PSMA摄取。提示PSMA抑制剂可能作为胶质母细胞瘤患者的诊断和治疗药物。

要点

  • 68Ga-PSMA-11 PET/CT在前列腺癌再分期时偶然检出胶质母细胞瘤术后残留。
  • 胶质母细胞瘤肿瘤相关新生血管可过表达PSMA。
  • PSMA抑制剂可能用于胶质母细胞瘤的诊断与治疗。

核心结论

  • 68Ga-PSMA-11 PET/CT可显示胶质母细胞瘤根治术后残留病灶的PSMA摄取。
  • PSMA抑制剂可能作为胶质母细胞瘤患者的诊断和治疗药物。

研究设计与样本

  • 个案报道:一名67岁有前列腺癌病史的男性,因胶质母细胞瘤行根治术后,再行68Ga-PSMA-11 PET/CT重新分期前列腺癌。

主要发现

  • PET显像显示胶质母细胞瘤术后残留病灶有PSMA摄取。
  • 肿瘤相关新生血管可过表达PSMA,包括胶质母细胞瘤。

临床怎么用

  • 在前列腺癌患者中,68Ga-PSMA-11 PET/CT可能同时检出胶质母细胞瘤术后残留的PSMA摄取。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prostate-specific membrane antigen (PSMA) is a transmembrane enzyme also known as folate hydrolase 1 highly expressed by prostate cancer (PCa) cells. However, PSMA overexpression by tumor-associated neovasculature of a variety of solid tumors, including glioblastoma (GBM), has also been proven. This clinical case reports about a 67-year-old man with a history of PCa who underwent radical surgery for GBM and performed a Ga-PSMA-11 PET/CT to restage PCa. PET imaging showed PSMA uptake in GBM residual disease after surgery. This finding suggests a possible role of PSMA inhibitors as diagnostic and therapeutic agents in patients affected by GBM.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Pilati E, Nicolotti DG, Ceci F, et al. 68Ga-Prostate-Specific Membrane Antigen 11 PET/CT Detects Residual Glioblastoma After Radical Surgery in a Patient With Synchronous Recurrent Prostate Cancer: A Case Report. Clin Nucl Med. 2020. PMID: 31876821. doi:10.1097/RLU.0000000000002884

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。